PMS51 COST-MINIMIZATION ANALYSIS OF IV BISPHOSPHONATES FOR RISK REDUCTION OF POST-MENOPAUSE VERTEBRAL AND NON-VERTEBRAL FRACTURES UNDER THE PRIVATE PAYER PERSPECTIVE IN BRAZIL
Abstract
Authors
MG Saggia MA Paschoalin EA Santos LG Borges